Abstract
We report on a patient with late-onset, pantothenate kinase-associated neurodegeneration (PKAN) who revealed two new heterozygous mutations at gene testing and showed asymmetric moderately reduced striatal dopamine transporter binding with single photon emission computed tomography, possibly due to prolonged neuroleptic treatment. These findings expand the genetic and imaging spectrum of this rare disorder.
Original language | English |
---|---|
Pages (from-to) | 417-418 |
Number of pages | 2 |
Journal | Movement Disorders |
Volume | 21 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2006 |
Keywords
- DatSCAN/SPECT
- Genetic
- MRI
- PKAN
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)